A Dual-Test Solution for Canine Blood Parasites
- The InCycle Canine VBD 2-in-1 Panel is a molecular diagnostic product developed for common tick-borne blood parasite infections in dogs. It is primarily used for rapid screening of two important pathogens: Babesia canis and Babesia gibsoni.
- Babesiasis is one of the most common blood-borne diseases in dogs, mainly transmitted through tick bites, but can also occur through blood contact. After infection, dogs may exhibit symptoms such as anemia, lethargy, fever, decreased appetite, and abnormal urine color. Because clinical symptoms vary at different stages of infection, relying solely on symptom observation or routine blood indicators is often insufficient to accurately determine the specific pathogen.
- The InCycle Canine VBD 2-in-1 Panel provides more accurate etiological evidence for veterinary clinical diagnosis by simultaneously covering two major canine babesiosis pathogens in a single test, helping to achieve early screening, infection identification, and subsequent treatment planning.

Target Pathogens Detected
This detection panel is designed to detect the following two types of Babesia canis:
1,Babesia canis (B. canis)
Includes:
- Babesia canis canis
- Babesia canis vogeli
Babesia canis is an important type of Babesia canis infection, which can affect the health of red blood cells in dogs, causing varying degrees of hemolytic anemia and related clinical manifestations.
2,Babesia gibsoni (B. gibsoni)
Babesia gibsoni is another common canine babesiosis pathogen, with a high risk of prevalence in some areas. Infection can lead to persistent anemia, abnormal immune responses, and a chronic infection state.
Product Features
Dual-target Integrated Detection Improves Clinical Screening Efficiency
Traditional clinical testing requires separate individual detection for different Babesia subspecies, which is time-consuming, labor-intensive, and delays the overall diagnosis and optimal intervention time. The InCycle Canine VBD 2-in-1 Panel integrates the two most common canine Babesia species into a single testing system and completes dual-pathogen screening in one test. For dogs with a history of outdoor activities in grasslands and forests or exposure to tick risks, it can quickly identify specific infection types, enable veterinarians to locate pathogens faster, and streamline the entire diagnosis process.
Specialized Identification of Canine Babesia Infection for Accurate Targeted Treatment
Infections caused by different Babesia species present highly similar clinical symptoms, including lethargy, decreased appetite, physical weakness, persistent fever, and anemia, making it difficult to distinguish subspecies through superficial observation. However, in actual clinical practice, different pathogens correspond to vastly different treatment plans, medication strategies, and postoperative care protocols. Failure to accurately identify the infection type may lead to inappropriate treatment, slow recovery, and recurrent illness. Designed specifically for canine Babesia detection, this testing panel accurately distinguishes pathogen types and provides reliable guidance for clinical medication and prognosis management.
Enables Early Screening of Asymptomatic Infections for Timely Intervention
Most dogs show atypical or mild symptoms in the early stage of Babesia infection, such as slight listlessness and reduced food intake, which are easily overlooked by pet owners and junior veterinarians. This can eventually develop into chronic infection or severe anemia. Adopting mature molecular detection technology, this product effectively captures low-load pathogens at the early infection stage. It screens for potential infections before severe symptoms appear, supports early discovery and clinical intervention, and greatly reduces the incidence of severe cases.
Eliminates Repeated Sampling and Testing to Fit High-frequency In-clinic Use
Traditional multi-pathogen detection requires repeated sampling and multiple tests, which increases pet stress and consumes more clinic consumables and working hours. The dual-target joint detection greatly simplifies operational procedures and completes two core screening items with a single sample. It effectively avoids redundant testing, improves the overall diagnosis efficiency of daily consultations, physical re-examinations and preoperative screenings, and is perfectly suitable for routine use in veterinary clinics.
Recommended Application Scenarios
Tick Exposure Testing in Dogs
+
-
The following dogs are recommended for Babesia screening:
- Dogs that frequently engage in outdoor activities
- Dogs living in areas with high tick prevalence
- Working dogs, hunting dogs
- Stray or rescue dogs
- Newly introduced dogs with unknown health status
Clinical symptoms can aid in diagnosis.
+
-
Testing may be considered when a dog exhibits the following:
- Unexplained anemia
- Persistent fever
- Poor mental state
- Decreased appetite
- Decreased activity
- Weight loss
- Jaundice
- Abnormal urine color
Health Management and Disease Monitoring
+
-
Suitable for:
- Routine health management in kennels
- Screening of breeding dogs in breeding facilities
- Health assessment in animal rescue organizations
- Preoperative infection risk screening
Recommended Sample Type
Sample Type:
- EDTA-anticoagulated whole blood
It is recommended to collect and preserve samples according to laboratory operating procedures to ensure the stability and reliability of test results.
Product Advantages
|
Product Advantages |
Description |
|
Dual-Pathogen Detection |
Simultaneously detects Babesia canis and Babesia gibsoni |
|
Covers Major Canine Babesia Types |
Includes Babesia canis canis and Babesia canis vogeli |
|
Improves Diagnostic Efficiency |
Reduces the need for multiple separate testing procedures |
|
Supports Differential Diagnosis |
Helps veterinarians distinguish between different infection sources |
|
Suitable for Veterinary Applications |
Designed to meet the testing needs of veterinary clinics and diagnostic laboratories |
Clinical Application Value
Canine babesia infection directly affects red blood cell function, potentially leading to significant anemia and systemic health problems in severe cases. Because early symptoms are often atypical, some cases can be easily confused with other diseases.
By detecting the two key pathogens, Babesia canis and Babesia gibsoni , the InCycle Canine VBD 2-in-1 Panel can help veterinarians more accurately understand the infection status of dogs, providing reliable support for disease diagnosis, treatment selection, and subsequent health management.
Applicable Institutions
Pet hospitals, animal clinics, veterinary testing laboratories, kennels and breeding facilities, animal rescue organizations, animal disease monitoring agencies.
For information on the InCycle Canine VBD 2-in-1 Panel's product specifications, testing procedures, sample requirements, bulk purchasing options, or regional distribution partnerships, please contact us for detailed information. Our professional team will provide you with suitable veterinary molecular testing solutions based on your diagnostic needs and market application scenarios.
Hot Tags: incycle canine vbd 2-in-1 panel, China incycle canine vbd 2-in-1 panel manufacturers, suppliers, factory, InCycle Canine VBD 2 in 1 Panel, InCycle Canine VBD 6 in 1 Panel, InCycle Feline Blood Screening 6 in 1 Panel, incycle reagents for vector borne disease

